GO:0008897 holo-[acyl-carrier-protein] synthase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008897 describes the enzymatic transfer of the 4'-phosphopantetheine (Ppant) cofactor from coenzyme A to a conserved serine residue on acyl-carrier or peptidyl-carrier proteins, converting them from apo to holo form.
• This activity is essential for fatty acid biosynthesis, polyketide and nonribosomal peptide synthesis, and secondary metabolism in bacteria, plants, and fungi.
• The Escherichia coli holo-acyl carrier protein synthase (AcpS) is the prototypical enzyme for this activity and has been structurally and biochemically characterized.
• A single mutation in the DSL motif of acyl carrier protein can prevent in vivo phosphopantetheinylation by E. coli AcpS, highlighting substrate recognition determinants.
• Loss of β-ketoacyl acyl carrier protein synthase III activity, which depends on holo-ACP, can restore antibiotic sensitivity in multidrug-resistant E. coli.
• Studying GO:0008897 requires combining genetic knockouts, point mutations, structural biology, and biochemical assays to dissect its role in metabolism and drug resistance.
Description
Holo-[acyl-carrier-protein] synthase activity (GO:0008897) is a molecular function that catalyzes the transfer of the 4'-phosphopantetheine (Ppant) moiety from coenzyme A to a conserved serine residue on acyl-carrier proteins (ACPs) or peptidyl-carrier proteins (PCPs), converting them from the inactive apo form to the active holo form. This post-translational modification is essential for the function of carrier proteins that shuttle growing fatty acid, polyketide, and nonribosomal peptide chains during biosynthesis. The reaction produces adenosine 3',5'-bisphosphate as a byproduct and is required for the proper folding and activity of numerous biosynthetic enzymes. In Escherichia coli, the enzyme AcpS is the primary holo-ACP synthase and is indispensable for fatty acid synthesis and cell viability. Beyond bacteria, plant holo-(acyl carrier protein) synthase has been biochemically characterized, underscoring the evolutionary conservation of this activity. Researchers study GO:0008897 to understand fundamental metabolic pathways, to develop antibiotics targeting fatty acid biosynthesis, and to engineer biosynthetic pathways for natural product production.
holo-[acyl-carrier-protein] synthase activity At A Glance
| GO ID | GO:0008897 |
|---|---|
| GO term | holo-[acyl-carrier-protein] synthase activity |
| Ontology | molecular_function |
| Synonym | 4'-phosphopantetheinyl transferase activity; AcpS; PPTase; holo-ACP synthase activity; acyl carrier protein synthase activity |
| Major function | Transfer of 4'-phosphopantetheine from CoA to a conserved serine on acyl- or peptidyl-carrier proteins, converting apo to holo form |
| Reaction | CoA + substrate-serine = adenosine 3',5'-bisphosphate + substrate-serine-4'-phosphopantetheine |
| Cofactor | Coenzyme A (CoA) as the Ppant donor; Mg2+ may be required |
| Localization | Cytoplasm in bacteria; plastid in plants |
| Pathways | Fatty acid biosynthesis, polyketide synthesis, nonribosomal peptide synthesis |
What Is GO:0008897?
According to the Gene Ontology, GO:0008897 (holo-[acyl-carrier-protein] synthase activity) is defined as the catalysis of the reaction: CoA + substrate-serine = adenosine 3',5'-bisphosphate + substrate-serine-4'-phosphopantetheine. This activity transfers the 4'-phosphopantetheine (Ppant) cofactor from coenzyme A to the hydroxyl side chain of a serine residue on an acyl-carrier protein (ACP) or peptidyl-carrier protein (PCP), thereby converting the apo form of the carrier protein to its holo form. The reaction is essential for activating carrier proteins involved in fatty acid, polyketide, and nonribosomal peptide biosynthesis.
Why Is holo-[acyl-carrier-protein] synthase activity Important in Cell Biology?
GO:0008897 is critical because it activates carrier proteins that are central to fatty acid biosynthesis, a pathway essential for membrane integrity and cell viability in bacteria. In E. coli, AcpS is the sole holo-ACP synthase, making it a potential antibacterial target. The activity also plays a key role in secondary metabolism, including the production of antibiotics and other natural products by nonribosomal peptide synthetases and polyketide synthases. In plants, holo-(acyl carrier protein) synthase is required for fatty acid synthesis in plastids, affecting seed oil composition and plant development. Understanding this activity provides insights into metabolic engineering, drug discovery, and fundamental enzymology.
• Essential for fatty acid biosynthesis in bacteria, plants, and other organisms.
• Required for activation of acyl-carrier proteins (ACPs) and peptidyl-carrier proteins (PCPs) in polyketide and nonribosomal peptide pathways.
• Potential target for antibacterial drug development, especially against multidrug-resistant pathogens.
• Involved in the production of secondary metabolites, including antibiotics and siderophores.
• Mutations in the DSL motif of ACP can disrupt phosphopantetheinylation, affecting cell viability.
• Structural studies reveal high-affinity complex formation and negative cooperativity, informing inhibitor design.
• Plays a role in plant fatty acid synthesis, impacting oilseed crops.
• Can be exploited for biotechnological applications, such as enhancing protein stability and immobilization.
Molecular Mechanism of holo-[acyl-carrier-protein] synthase activity
Substrate Recognition and Binding
In simple terms: The enzyme first grabs the carrier protein and coenzyme A.
Holo-[acyl-carrier-protein] synthase (AcpS) recognizes its substrate, apo-ACP, through specific protein-protein interactions. The enzyme binds the conserved DSL motif (Asp-Ser-Leu) of ACP, positioning the target serine residue for modification. Coenzyme A (CoA) binds in the active site, and the 4'-phosphopantetheine moiety is transferred to the serine hydroxyl group. Structural studies of the E. coli AcpS-ACP complex reveal a high-affinity interaction with negative cooperativity, suggesting a regulated binding mechanism.
Catalytic Transfer of 4'-Phosphopantetheine
In simple terms: The enzyme snips off a chemical tag from CoA and attaches it to the carrier protein.
The catalytic mechanism involves the nucleophilic attack of the serine hydroxyl on the phosphodiester bond of CoA, releasing adenosine 3',5'-bisphosphate and forming a covalent bond between the serine and the 4'-phosphopantetheine group. This reaction converts apo-ACP to holo-ACP, enabling the carrier protein to shuttle acyl intermediates during fatty acid synthesis. The enzyme requires a divalent metal ion, typically Mg2+, for optimal activity.
Post-Translational Activation of Carrier Proteins
In simple terms: The modification turns on the carrier protein so it can carry fatty acid chains.
Phosphopantetheinylation is a post-translational modification that activates ACPs and PCPs by providing a flexible thiol arm for tethering growing acyl chains. Without this modification, carrier proteins remain in the apo form and cannot participate in fatty acid, polyketide, or nonribosomal peptide biosynthesis. In E. coli, AcpS is the sole enzyme responsible for this activation, making it essential for lipid metabolism and cell growth.
Structural Features of the Enzyme
In simple terms: The enzyme has a specific shape that fits its substrates.
AcpS is a small, homodimeric protein with a characteristic alpha/beta fold. The active site is formed at the dimer interface and contains residues that coordinate CoA and the ACP serine. Structural analyses have revealed that the enzyme undergoes conformational changes upon substrate binding, facilitating catalysis. The high-affinity complex between AcpS and ACP (dissociation constant in the nanomolar range) underscores the specificity of this interaction.
Regulation and Inhibition
In simple terms: The enzyme's activity can be turned up or down by cellular signals and inhibitors.
The activity of holo-[acyl-carrier-protein] synthase is regulated at multiple levels, including gene expression and feedback inhibition by pathway intermediates. In E. coli, AcpS expression is constitutive, but its activity can be modulated by the availability of CoA and apo-ACP. Small-molecule inhibitors of AcpS have been explored as potential antibiotics, and mutations in the DSL motif of ACP can confer resistance to phosphopantetheinylation. Additionally, the enzyme's interaction with ACP is subject to negative cooperativity, which may serve as a regulatory mechanism.
Key Genes Involved in GO:0008897 holo-[acyl-carrier-protein] synthase activity
The following genes and proteins are directly involved in or regulated by holo-[acyl-carrier-protein] synthase activity (GO:0008897).
| Gene | Major Role | Research Relevance |
|---|---|---|
| acpS (E. coli) | Encodes holo-ACP synthase, the enzyme that transfers Ppant to ACP | Model enzyme for studying GO:0008897; essential for fatty acid synthesis |
| acpP (E. coli) | Encodes acyl carrier protein, the substrate for AcpS | Mutations in DSL motif affect phosphopantetheinylation |
| fabH (E. coli) | Encodes β-ketoacyl-ACP synthase III, which uses holo-ACP | Loss of activity restores antibiotic sensitivity |
| acpS (B. subtilis) | Ortholog of AcpS, involved in fatty acid and secondary metabolism | Potential target for antibacterial development |
| acpS (M. tuberculosis) | Holo-ACP synthase in a major pathogen | Target for anti-tuberculosis drugs |
| acpS (plants) | Holo-(acyl carrier protein) synthase in plastids | Required for fatty acid synthesis and seed oil production |
| pptT (S. coelicolor) | Phosphopantetheinyl transferase for polyketide synthases | Involved in antibiotic production |
| sfp (B. subtilis) | Phosphopantetheinyl transferase for nonribosomal peptide synthetases | Model for PCP modification |
| acpS (P. aeruginosa) | Holo-ACP synthase in opportunistic pathogen | Antibiotic target |
| acpS (S. aureus) | Holo-ACP synthase in Gram-positive pathogen | Essential for viability; drug target |
| acpS (H. pylori) | Holo-ACP synthase in gastric pathogen | Potential therapeutic target |
| acpS (V. cholerae) | Holo-ACP synthase in cholera pathogen | Antibacterial target |
| acpS (N. meningitidis) | Holo-ACP synthase in meningitis pathogen | Vaccine and drug target |
| acpS (T. thermophilus) | Thermostable holo-ACP synthase | Structural and biochemical studies |
| acpS (yeast) | Holo-ACP synthase in fungi | Fatty acid synthesis and mitochondrial function |
| acpS (D. melanogaster) | Holo-ACP synthase in insects | Developmental and metabolic studies |
| acpS (human) | No direct human ortholog; mitochondrial ACP requires phosphopantetheinylation | Mitochondrial fatty acid synthesis |
How Is holo-[acyl-carrier-protein] synthase activity Regulated?
The activity of holo-[acyl-carrier-protein] synthase (GO:0008897) is regulated primarily at the level of substrate availability and protein-protein interactions. In E. coli, AcpS is constitutively expressed, but its activity depends on the availability of apo-ACP and coenzyme A. The enzyme forms a high-affinity complex with ACP, and negative cooperativity in this interaction may modulate activity under varying cellular conditions. Additionally, mutations in the DSL motif of ACP can abolish phosphopantetheinylation, indicating that substrate recognition is a key regulatory point. In plants, holo-(acyl carrier protein) synthase activity is regulated by light and developmental signals, influencing fatty acid synthesis in plastids. Small-molecule inhibitors and feedback inhibition by pathway intermediates also contribute to regulation.
holo-[acyl-carrier-protein] synthase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| acpS (E. coli) | Bacterial infections, antibiotic resistance | KO and point-mutation strains; antibiotic sensitivity assays |
| acpS (M. tuberculosis) | Tuberculosis | Conditional knockout in M. tuberculosis; inhibitor screening |
| acpS (plants) | Seed oil composition, plant development | Arabidopsis knockout and overexpression lines |
| sfp (B. subtilis) | Antibiotic production, secondary metabolism | Deletion mutants; heterologous expression |
| acpP (E. coli) | Fatty acid synthesis, cell viability | DSL motif point mutants; in vivo phosphopantetheinylation assays |
Bacterial Infections and Antibiotic Resistance
Holo-[acyl-carrier-protein] synthase activity is essential for bacterial fatty acid synthesis, making it a target for antibiotics. In multidrug-resistant E. coli, loss of β-ketoacyl ACP synthase III activity, which depends on holo-ACP, can restore sensitivity to previously ineffective antibiotics. This highlights the potential of targeting GO:0008897 to overcome resistance.
Tuberculosis and Other Mycobacterial Diseases
Mycobacterium tuberculosis relies on holo-ACP synthase for mycolic acid biosynthesis, a key component of its cell wall. Inhibitors of this activity are being explored as novel anti-tuberculosis agents.
Metabolic Disorders and Plant Oil Production
In plants, holo-(acyl carrier protein) synthase is required for fatty acid synthesis in plastids, affecting seed oil composition and yield. Modulating this activity could improve oilseed crops for food and biofuel production.
Natural Product Biosynthesis and Drug Discovery
Phosphopantetheinyl transferases (PPTases) activate carrier proteins in polyketide and nonribosomal peptide pathways, which produce many antibiotics and anticancer agents. Understanding GO:0008897 can aid in engineering these pathways for drug discovery.
From holo-[acyl-carrier-protein] synthase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is acpS essential for bacterial viability? | CRISPR knockout or conditional knockdown in E. coli |
| How does the DSL motif affect phosphopantetheinylation? | Point mutations in acpP (e.g., S36A) |
| Can AcpS be targeted by antibiotics? | Overexpression and knockout strains for inhibitor testing |
| What is the structure of the AcpS-ACP complex? | Tagged knock-in for cryo-EM or X-ray crystallography |
| Does acpS affect plant oil composition? | Knockout and overexpression in Arabidopsis |
| Can PPTases be engineered for novel substrates? | Directed evolution and library screening |
How to Study the holo-[acyl-carrier-protein] synthase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro phosphopantetheinylation assay | Conversion of apo-ACP to holo-ACP | Enzyme kinetics and inhibitor testing |
| Mass spectrometry | Mass shift due to Ppant addition | Confirming modification and stoichiometry |
| X-ray crystallography | Three-dimensional structure of AcpS-ACP complex | Understanding substrate binding and catalysis |
| CRISPR knockout | Loss of acpS function | Essentiality studies and antibiotic target validation |
| Site-directed mutagenesis | Effect of specific residues on activity | Mapping DSL motif and active site |
| Isothermal titration calorimetry | Binding affinity between AcpS and ACP | Quantifying protein-protein interactions |
| Antibiotic sensitivity assays | Minimum inhibitory concentration (MIC) | Evaluating synergy with AcpS inhibitors |
| Heterologous expression | Production of active PPTases | Engineering biosynthetic pathways |
Biochemical Assays for Phosphopantetheinylation
In vitro assays using purified apo-ACP and AcpS in the presence of CoA can measure the formation of holo-ACP. Detection methods include gel electrophoresis, mass spectrometry, and radioactive labeling with 14C-CoA.
Structural Biology (X-ray Crystallography and Cryo-EM)
Structures of AcpS alone and in complex with ACP have been solved, revealing the active site and interaction interface. These methods are essential for understanding substrate recognition and designing inhibitors.
Genetic Knockouts and Point Mutations
CRISPR-Cas9 or allelic exchange can generate acpS knockouts or point mutations in the DSL motif of acpP. These models are used to study essentiality and resistance mechanisms.
High-Throughput Screening for Inhibitors
Libraries of small molecules can be screened for inhibition of AcpS activity using fluorescence-based assays or growth inhibition of bacteria.
How CRISPR Can Be Used to Study GO:0008897 holo-[acyl-carrier-protein] synthase activity
Knockout
CRISPR-Cas9 knockout of acpS in E. coli is lethal, confirming its essentiality. Conditional knockouts using inducible promoters allow studying depletion phenotypes. In plants, knockout of holo-(acyl carrier protein) synthase affects fatty acid synthesis and seed development.
Point Mutation
Point mutations in the DSL motif of acpP (e.g., S36A) prevent phosphopantetheinylation by AcpS, leading to loss of fatty acid synthesis and cell death. Such mutants are valuable for dissecting substrate recognition and for screening suppressors.
Knock-in
Knock-in of tagged acpS (e.g., FLAG or GFP) allows visualization and pull-down of the enzyme for interaction studies. Knock-in of mutant acpS alleles can be used to test structure-function relationships in vivo.
Overexpression
Overexpression of acpS or sfp in heterologous hosts enhances production of polyketides and nonribosomal peptides by increasing holo-ACP/PCP formation. This strategy is widely used in metabolic engineering.
How EDITGENE Supports holo-[acyl-carrier-protein] synthase activity Research
Researchers studying holo-[acyl-carrier-protein] synthase activity-related genes often need to determine whether a candidate gene is causally involved in fatty acid synthesis, secondary metabolism, or antibiotic resistance. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for holo-[acyl-carrier-protein] synthase activity research.
Frequently Asked Questions About holo-[acyl-carrier-protein] synthase activity
What is holo-[acyl-carrier-protein] synthase activity?
It is the enzymatic activity (GO:0008897) that transfers the 4'-phosphopantetheine group from coenzyme A to a conserved serine on acyl-carrier proteins, converting them from apo to holo form.
What genes are involved in holo-[acyl-carrier-protein] synthase activity?
Key genes include acpS (encoding the synthase) and acpP (encoding the acyl carrier protein substrate), as well as PPTase genes like sfp.
Why is holo-[acyl-carrier-protein] synthase important for bacteria?
It is essential for fatty acid synthesis and cell viability, making it a potential antibiotic target.
How is holo-[acyl-carrier-protein] synthase activity regulated?
It is regulated by substrate availability, protein-protein interactions, and feedback inhibition; the DSL motif of ACP is critical for recognition.
What diseases are associated with holo-[acyl-carrier-protein] synthase dysfunction?
Dysfunction can impair fatty acid synthesis, affecting bacterial infections and plant oil production; it is not directly linked to human genetic diseases.
Can holo-[acyl-carrier-protein] synthase be targeted by antibiotics?
Yes, inhibitors of AcpS are being explored as novel antibiotics, especially against multidrug-resistant bacteria.
What methods are used to study holo-[acyl-carrier-protein] synthase activity?
Common methods include in vitro phosphopantetheinylation assays, mass spectrometry, X-ray crystallography, and CRISPR knockouts.
What is the DSL motif in acyl carrier protein?
The DSL motif (Asp-Ser-Leu) is a conserved sequence in ACP that is recognized by holo-ACP synthase; mutations can prevent phosphopantetheinylation.
How does holo-[acyl-carrier-protein] synthase relate to polyketide synthesis?
It activates PCPs and ACPs in polyketide synthases, which produce many antibiotics and secondary metabolites.
What CRISPR models are available for studying holo-[acyl-carrier-protein] synthase?
EDITGENE offers knockout, point mutation, knock-in, and overexpression models in bacterial and plant systems.
Conclusion
Holo-[acyl-carrier-protein] synthase activity (GO:0008897) is a fundamental enzymatic function that activates carrier proteins for fatty acid, polyketide, and nonribosomal peptide biosynthesis. Its essential role in bacteria and plants makes it a valuable target for antibiotic development and metabolic engineering. By combining biochemical, structural, and CRISPR-based approaches, researchers can dissect its mechanism and regulation, paving the way for new therapeutic and biotechnological applications.
References
- 1. Flugel RS et al.. 2000. Holo-(acyl carrier protein) synthase and phosphopantetheinyl transfer in Escherichia coli.. J Biol Chem 275(2):959-68 PMID: 10625633
- 2. Elhussein SA et al.. 1988. Plant holo-(acyl carrier protein) synthase.. Biochem J 252(1):39-45 PMID: 2844150
- 3. Lambalot RH et al.. 1995. Cloning, overproduction, and characterization of the Escherichia coli holo-acyl carrier protein synthase.. J Biol Chem 270(42):24658-61 PMID: 7559576
- 4. Dhembla C et al.. 2025. A Single Mutation in the "DSL" Motif of the Acyl Carrier Protein Can Prevent Its In Vivo Phosphopantetheinylation by E. coli Holo-Acyl Carrier Protein Synthase (AcpS).. Biochemistry 64(18):3986-3999 PMID: 40900008
- 5. Hong Y et al.. 2022. Loss of β-Ketoacyl Acyl Carrier Protein Synthase III Activity Restores Multidrug-Resistant Escherichia coli Sensitivity to Previously Ineffective Antibiotics.. mSphere 7(3):e0011722 PMID: 35574679
- 6. Marcella AM et al.. 2017. Structure, High Affinity, and Negative Cooperativity of the Escherichia coli Holo-(Acyl Carrier Protein):Holo-(Acyl Carrier Protein) Synthase Complex.. J Mol Biol 429(23):3763-3775 PMID: 29054754
- 7. Li X et al.. 2023. Acyl carrier protein tag can enhance tobacco etch virus protease stability and promote its covalent immobilisation.. Appl Microbiol Biotechnol 107(5-6):1697-1705 PMID: 36763116
- 8. Jaremko MJ et al.. 2017. Manipulating Protein-Protein Interactions in Nonribosomal Peptide Synthetase Type II Peptidyl Carrier Proteins.. Biochemistry 56(40):5269-5273 PMID: 28920687
